Money Concepts Capital Corp Nu Cana PLC Transaction History

Money Concepts Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$0.74 - $3.27 $2,479 - $10,954	3,350 New	3,350 $3,000
Q4 2021 Feb 14, 2022	SELL	$2.02 - $2.9 $23,817 - $34,193	-11,791 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.38 - $7.0 $4,380 - $7,000	-1,000 Reduced 7.82%	11,791 $59,000
Q4 2020 May 17, 2021	BUY	$4.4 - $5.59 $56,280 - $71,501	12,791 New	12,791 $57,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $48.5M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.